Variation in the TLR4 gene influences the risk of organ failure and shock posttrauma: a cohort study.

BACKGROUND Genetic variation contributes to risk and outcomes of sepsis. We sought to determine whether variation in inflammation related genes is associated with severity of sepsis in trauma patients. METHODS A cohort of severely injured Caucasian patients was studied and genotyped for candidate single nucleotide polymorphisms (SNPs). These were toll-like receptor 4 (TLR4) A896G, tumor necrosis factor-alpha G-308A, interleukin-6 G-174C, interleukin-1beta C-31T, and cluster of differentiation marker 14C-159T. SNP genotypes among patients with sepsis and complicated sepsis were analyzed by chi2 and logistic regression. Six haplotype-tagging SNPs in the TLR4 gene were subsequently examined to analyze their influence on TLR4 A896G SNPs relationship to sepsis severity. RESULTS We enrolled 598 patients. Complicated sepsis developed in 147 (25%). Adjusting for independent risk factors, carriage of the variant TLR4 896 G allele was associated with decreased risk of complicated sepsis (odds ratio = 0.3, 95% confidence interval, 0.1-0.7, p = 0.008). Furthermore, two haplotypes seemed to better characterize this risk than the variant TLR4 896G allele. The variant TLR4 896G allele is linked to one common haplotype, which seems to confer a considerably reduced risk of complicated sepsis. (aOR = 0.2 95% confidence interval, 0.05-0.7, p = 0.01). CONCLUSIONS Variation within TLR4 gene is associated with severity of posttraumatic sepsis. This risk may not be solely related to TLR4 A896G SNP. It is likely that other, uncharacterized variations in the TLR4 gene contribute to sepsis severity. A thorough evaluation of variability within the TLR4 gene is needed to characterize sepsis risk.

[1]  I. König,et al.  Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor* , 2008, Critical care medicine.

[2]  J. Hunt,et al.  Innate immunity SNPs are associated with risk for severe sepsis after burn injury. , 2006, Clinical medicine & research.

[3]  V. Álvarez,et al.  The Toll‐like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram‐negative and haematogenous osteomyelitis , 2006, Clinical and experimental immunology.

[4]  Zhongming Zhao,et al.  Sequence context analysis of 8.2 million single nucleotide polymorphisms in the human genome. , 2006, Gene.

[5]  S. Jelacic,et al.  The TLR4 +896 polymorphism is not associated with lipopolysaccharide hypo-responsiveness in leukocytes , 2005, Genes and Immunity.

[6]  G. O’Keefe,et al.  Innate Immunity Genes Influence the Severity of Acute Appendicitis , 2004, Annals of surgery.

[7]  R. Rylander,et al.  Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. , 2003, The Journal of allergy and clinical immunology.

[8]  D. Kunz,et al.  The cytokine synthesis by heterozygous carriers of the Toll-like receptor 4 Asp299Gly polymorphism does not differ from that of wild type homozygotes. , 2003, European cytokine network.

[9]  T. Hartung,et al.  Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. , 2003, The Journal of infectious diseases.

[10]  S. Blecher,et al.  Upregulation of Reactive Oxygen Species Generation and Phagocytosis, and Increased Apoptosis in Human Neutrophils During Severe Sepsis and Septic Shock , 2003, Shock.

[11]  C. Erridge,et al.  Monocytes Heterozygous for the Asp299Gly and Thr399Ile Mutations in the Toll-like Receptor 4 Gene Show No Deficit in Lipopolysaccharide Signalling , 2003, The Journal of experimental medicine.

[12]  J. Holloway,et al.  Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. , 2003, Biochemical Society transactions.

[13]  B. Beutler,et al.  Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[15]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[16]  S. Calvano,et al.  Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. , 2002, The Journal of infectious diseases.

[17]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[18]  D. Schwartz,et al.  Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. , 2002, Archives of internal medicine.

[19]  G. O’Keefe,et al.  The G-->A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. , 2002, The Journal of trauma.

[20]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[21]  R. Codoceo,et al.  Interleukin‐1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis , 2002, Clinical and Experimental Immunology.

[22]  C. Cannings,et al.  A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. , 2001, The Journal of infectious diseases.

[23]  A. Di Rienzo,et al.  Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. , 2001, Genetics.

[24]  G. O’Keefe,et al.  Objective estimates of the incidence and consequences of multiple organ dysfunction and sepsis after burn trauma. , 2001, The Journal of trauma.

[25]  D. Schwartz,et al.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.

[26]  G. O’Keefe,et al.  The complications of trauma and their associated costs in a level I trauma center. , 1997, Archives of surgery.

[27]  D. Boomsma,et al.  Genetic influence on cytokine production and fatal meningococcal disease , 1997, The Lancet.

[28]  C. Sprung,et al.  Multiple Organ Dysfunction Score , 1996 .

[29]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[30]  P. Andersen,et al.  Genetic and environmental influences on premature death in adult adoptees. , 1988, The New England journal of medicine.

[31]  S. Vermeire,et al.  Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease. , 2007, Microbes and infection.

[32]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.